Latest News and Press Releases

Company Announces Strategic Realignment to Focus on Core Programs and Extend Cash Runway Icovamenib progressing toward the next phase of clinical development in insulin deficient type 2 diabetes...

MINNEAPOLIS, May 03, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), presented significant...

New York City, April 18, 2025 (GLOBE NEWSWIRE) -- Introduction: Understanding the Diabetes Epidemic Type 2 diabetes has become one of the most pressing public health concerns of the 21st century....

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin...

Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pen Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...

Inflammasome inhibition in obese animal model with heart failure was cardioprotective & improved metabolic parameters.

Dublin, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast" report has been added to ...

Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Smart Insulin Pens and Pumps - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The peptide API market has shown promising growth in recent years, reaching a valuation of US$ 9.2...

Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Continuous Glucose Monitoring (CGM) Market, 2025-2033" report has been added to ResearchAndMarkets.com's offering.The United States...